NCT06595992Recruiting
Prospective Observational Cohort Study of Moderate Aortic Valve Disease
EVOLUTION: Prospective Observational Cohort Study of Moderate Aortic Valve Disease
Source: ClinicalTrials.gov · Last updated 19 Sept 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The objective of this research is to evaluate and predict the progression of moderate aortic stenosis and regurgitation from clinical characterization, biological, echocardiographic, and computed tomography (CT) et. al. Additionally, try to analyze the potential impact of device or drug therapy on the progression of the conditions.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 30 Aug 2024
- Start date
- 1 Sept 2024
- Primary completion date
- 31 Jan 2034
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Diseases
- Heart failure
- NCT number
- NCT06595992
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Sept 2024 to the primary completion date, 31 Jan 2034
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe aortic valve diseases with echocardiographically derived criteria or planned cardiac surgery or likely need for surgery within 6 months
- Life expectancy is less than 12 months due to non-heart disease (such as cancer, chronic liver disease, chronic kidney disease, or chronic end-stage lung disease, etc.)
- Severe dementia (cannot sign research informed consent, cannot take care of themselves or complete the study visit)
Other
- Patients who have undergone elective transfemoral transcatheter aortic valve replacement
- Acute pulmonary oedema or cardiogenic shock
- The investigator believes that the patient is not suitable to participate in the study or complete the follow-up prescribed by the protocol from other medical, social and psychological aspects
- The patient is currently participating in another randomized study
Who the study is looking for
- At least 18 years old
- Be willing and able to provide informed consent to participate in the study
- Patient has moderate aortic valve diseases with echocardiographically derived criteria
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Second Affiliated Hospital of Zhejiang University School of Medicine Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.